United States · FDA National Drug Code directory
Cyclobenzaprine HCL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85509-1001_488202dc-28f3-ad46-e063-6294a90a4238
- Product NDC
- 85509-1001
- Form
- TABLET, FILM COATED
- Composition / generic term
- Cyclobenzaprine HCL
- Labeler
- PHOENIX RX LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150325
- Source listing expiry
- 20271231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 7.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET, FILM COATED in 1 BOTTLE (85509-1001-1) · 85509-1001-1
- 30 TABLET, FILM COATED in 1 BOTTLE (85509-1001-3) · 85509-1001-3
- 60 TABLET, FILM COATED in 1 BOTTLE (85509-1001-6) · 85509-1001-6
- 90 TABLET, FILM COATED in 1 BOTTLE (85509-1001-9) · 85509-1001-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →